These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10180734)

  • 1. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler.
    Borgström L; Asking L; Beckman O; Bondesson E; Källén A; Olsson B
    J Aerosol Med; 1998; 11 Suppl 1():S59-64. PubMed ID: 10180734
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and testing of aerosol delivery systems for reproducible clinical performance.
    Cipolla DC; Farr SJ; Gonda I; Herst CV; Lee RY; Lloyd P; McKinley G; Rubsamen R; Schuster J; Zellhoefer C
    J Aerosol Med; 1998; 11 Suppl 1():S84-8. PubMed ID: 10180738
    [No Abstract]   [Full Text] [Related]  

  • 3. Aerosol device selection: evidence to practice.
    Fink JB
    Respir Care; 2000 Jul; 45(7):874-85. PubMed ID: 10926386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metered dose inhaler aerosol deposition in a model of the human respiratory system and a comparison with clinical deposition studies.
    Velasquez DJ; Gabrio B
    J Aerosol Med; 1998; 11 Suppl 1():S23-8. PubMed ID: 10180729
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance characteristics of pressurized metered dose inhalers in vitro.
    Byron PR
    J Aerosol Med; 1997; 10 Suppl 1():S3-6. PubMed ID: 10165120
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol delivery through an artificial airway.
    MacIntyre NR
    Respir Care; 2002 Nov; 47(11):1279-88; discussion 1285-9. PubMed ID: 12425743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How well do in vitro particle size measurements predict drug delivery in vivo?
    Newman SP
    J Aerosol Med; 1998; 11 Suppl 1():S97-104. PubMed ID: 10180741
    [No Abstract]   [Full Text] [Related]  

  • 9. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles.
    Geller DE
    Respir Care; 2002 Dec; 47(12):1392-404; discussion 1404-5. PubMed ID: 12467498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates.
    Feddah MR; Brown KF; Gipps EM; Davies NM
    J Pharm Pharm Sci; 2000; 3(3):318-24. PubMed ID: 11177650
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wei X; Hindle M; Kaviratna A; Huynh BK; Delvadia RR; Sandell D; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):358-371. PubMed ID: 29878859
    [No Abstract]   [Full Text] [Related]  

  • 13. The History of Therapeutic Aerosols: A Chronological Review.
    Stein SW; Thiel CG
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):20-41. PubMed ID: 27748638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, development and performance of a novel multidose dry-powder inhaler.
    Parry-Billings M; Boyes RN; Clisby LM; Braithwaite P; Williams S; Harper AE
    Med Device Technol; 1999 Nov; 10(9):24-8, 30, 32-4. PubMed ID: 10724653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate.
    Shrewsbury SB; Armer TA; Newman SP; Pitcairn G
    Int J Pharm; 2008 May; 356(1-2):137-43. PubMed ID: 18289809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosol therapy: the special needs of young children.
    Janssens HM; Tiddens HA
    Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized cross-over trial to assess the ability of a dry-powder inhaler to reverse the local side effects of pressurized metered-dose inhalers.
    Bhalla RK; Watson G; Taylor W; Jones AS; Roland NJ
    J Asthma; 2008 Nov; 45(9):814-9. PubMed ID: 18972301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
    de Boer AH; Hagedoorn P; Westerman EM; Le Brun PP; Heijerman HG; Frijlink HW
    Eur J Pharm Sci; 2006 Jun; 28(3):171-8. PubMed ID: 16650739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical aerosol electrostatics: a field with much potential for development.
    Lip Kwok PC
    Ther Deliv; 2015 Feb; 6(2):105-7. PubMed ID: 25690079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.